For instance, TNFRSF12A was determined to be an independent risk marker for the prognosis of IPF individuals in the training cohort; nevertheless, neither the test cohort nor the validation cohort supported this finding. This evidence concerns the gene TNFRSF12A and idiopathic pulmonary fibrosis.